Cancer stem cells in glioblastoma
Top Cited Papers
Open Access
- 15 June 2015
- journal article
- review article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 29 (12), 1203-1217
- https://doi.org/10.1101/gad.261982.115
Abstract
Tissues with defined cellular hierarchies in development and homeostasis give rise to tumors with cellular hierarchies, suggesting that tumors recapitulate specific tissues and mimic their origins. Glioblastoma (GBM) is the most prevalent and malignant primary brain tumor and contains self-renewing, tumorigenic cancer stem cells (CSCs) that contribute to tumor initiation and therapeutic resistance. As normal stem and progenitor cells participate in tissue development and repair, these developmental programs re-emerge in CSCs to support the development and progressive growth of tumors. Elucidation of the molecular mechanisms that govern CSCs has informed the development of novel targeted therapeutics for GBM and other brain cancers. CSCs are not self-autonomous units; rather, they function within an ecological system, both actively remodeling the microenvironment and receiving critical maintenance cues from their niches. To fulfill the future goal of developing novel therapies to collapse CSC dynamics, drawing parallels to other normal and pathological states that are highly interactive with their microenvironments and that use developmental signaling pathways will be beneficial.Keywords
Funding Information
- National Institutes of Health (CA154130, CA171652, CA169117, NS087913, NS089272, CA157948, NS083629)
- Sontag Foundation
- Cleveland Clinic
- James S. McDonnell Foundation
- Canadian Institutes of Health Research
- Lerner Research Institute
- Case Comprehensive Cancer Center
- Voices Against Brain Cancer
- Blast GBM
- Ohio Cancer Research Associates
- American Cancer Society (V Scholar Award)
- V Foundation for Cancer Research (IRG-91-022-18)
- American Cancer Society
This publication has 139 references indexed in Scilit:
- MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem CellsThe International Journal of Cell Cloning, 2013
- Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastomaCancer Immunology, Immunotherapy, 2012
- Cancer stem cells in gliomas: Identifying and understanding the apex cell in cancer's hierarchyGlia, 2011
- Seeing is Believing: Are Cancer Stem Cells the Loch Ness Monster of Tumor Biology?Stem Cell Reviews and Reports, 2010
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of GliomaCancer Cell, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor GrowthThe International Journal of Cell Cloning, 2009
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem CellsCancer Cell, 2009
- Epigenetic-Mediated Dysfunction of the Bone Morphogenetic Protein Pathway Inhibits Differentiation of Glioblastoma-Initiating CellsCancer Cell, 2008
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007